Success begins at the molecular level
Make precision medicine a reality
Precision medicine
individual solutions for complex challenges
Deep understanding of scientific data, for more clarity
With us, you’re on the right track
Previous
Next

Our technology

Globally-available data is adjusted, curated, and combined with artificial intelligence

Our target groups

Evidence-based results for physicians, laboratories, and pharma/biotech companies

Our applications

Computer-assisted decision-making aids for healthcare and research professionals

Latest News

Overcoming IVDR Challenges – A Webinar on November 8, 2022, at 18:00 CET

Join a unique virtual event examining the relevance of the new European In-Vitro Diagnostics Medical Device Regulation (EU)2017/746 (IVDR) for clinical laboratories. We share our experience in gaining IVDR certification for our clinical decision support solution MH Guide to give you a leg up.
We hope to see you for this free-to-attend webinar on November 8th, 2022, at 18:00 CET.
Click here to register.

Read more

We bring precision medicine to life

Bildschirmfoto 2021-01-14 um 08.46.08

Every day, the volume of medical and clinical knowledge is increasing:

For the year 2020, a study by the American Clinical and Climatological Association predicted a doubling time of about 73 days, compared with an estimated 3.5 years in 2010.* These data volumes can no longer be translated into specific treatment decisions by humans alone. This is particularly true where molecular relationships are used to understand and target diseases.

Molecular Health strives to make this mass of information available to physicians, laboratories, and pharma & biotech professionals, helping them come to evidence-based decisions.



*1. Densen P. Challenges and Opportunities Facing Medical Education. Transactions of the American Clinical and Climatological Association. 2011;122:48-58.

“We develop software solutions that transform Big Data into precise, actionable decisions for all stakeholders in healthcare.”

Dr. Stephan Brock
Chief Technology Officer

We help to target therapies and mitigate risks

Banane-auf-grau

For physicians

More accurate diagnoses, better decisions: Molecular genetic information about tumor diseases can be the key to more effective and tolerable therapies for your patients. Make evidence-based decisions using software-assisted molecular and genetic diagnoses and take full advantage of precision medicine.
Read more

For laboratories

Big Data analytics for labs: Benefit from our software solutions that enable clinical annotations of large datasets in comparison with current medical knowledge. Use our fast, customizable MH Guide platform for direct collaboration with patient care and research colleagues.
Read more

For pharma/biotech companies

Pick the winners: Increase the chance of successful clinical trials for your pharmaceutical development. We combine molecular data and biomedical drug knowledge in our database and work with you to assess the probable outcomes of your clinical trials, even before data collection begins.
Read more

For employers

Oncology care in Germany is outstanding, but not all patients benefit from the available diagnostic and therapeutic options. With our Corporate Oncology Program for Employees (COPE), companies have the opportunity to give their impacted employees straightforward access to comprehensive NGS tumor diagnostics and MH Guide evaluation, as part of an occupational health management program.
Read more

Harness globally-available insights from clinical molecular data for your success. Our applications:

For solid and ​ hematologic cancers​

The comprehensive application for automated interpretation of NGS data from any kind of solid or hematologic cancer
MH Guide quickly and accurately identifies and interprets genetic variants in cancer. The MH Guide report helps treatment providers choose therapy options and clinical trials that match the cancer patient’s molecular profile.
Find out more

For hereditary cancers​

Comprehensive applications for automated interpretation of NGS data from hereditary cancers
Our applications support you in identifying clinically-significant germline variants associated with hereditary breast and ovarian cancer syndrome (HBOC), or other hereditary cancers.
Find out more

Contact form